These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Involvement of noradrenergic and corticoid receptors in the consolidation of the lasting anxiogenic effects of predator stress. Adamec R; Muir C; Grimes M; Pearcey K Behav Brain Res; 2007 May; 179(2):192-207. PubMed ID: 17335916 [TBL] [Abstract][Full Text] [Related]
7. Prazosin for the treatment of posttraumatic stress disorder sleep disturbances. Miller LJ Pharmacotherapy; 2008 May; 28(5):656-66. PubMed ID: 18447662 [TBL] [Abstract][Full Text] [Related]
8. The biologic basis of posttraumatic stress. van der Kolk BA; Fisler RE Prim Care; 1993 Jun; 20(2):417-32. PubMed ID: 8356161 [TBL] [Abstract][Full Text] [Related]
10. Tracing the flow of knowledge: geographic variability in the diffusion of prazosin use for the treatment of posttraumatic stress disorder nationally in the Department of Veterans Affairs. Harpaz-Rotem I; Rosenheck RA Arch Gen Psychiatry; 2009 Apr; 66(4):417-21. PubMed ID: 19349311 [TBL] [Abstract][Full Text] [Related]
11. Preliminary findings concerning the use of prazosin for the treatment of posttraumatic nightmares in a refugee population. Boynton L; Bentley J; Strachan E; Barbato A; Raskind M J Psychiatr Pract; 2009 Nov; 15(6):454-9. PubMed ID: 19934720 [TBL] [Abstract][Full Text] [Related]
12. The psychobiology of posttraumatic stress disorder. Nutt DJ J Clin Psychiatry; 2000; 61 Suppl 5():24-9; discussion 30-2. PubMed ID: 10761676 [TBL] [Abstract][Full Text] [Related]
13. α-Adrenergic receptor function, arousal and sleep: mechanisms and therapeutic implications. Broese M; Riemann D; Hein L; Nissen C Pharmacopsychiatry; 2012 Sep; 45(6):209-16. PubMed ID: 22290201 [TBL] [Abstract][Full Text] [Related]
14. Noradrenergic signaling in the amygdala contributes to the reconsolidation of fear memory: treatment implications for PTSD. Debiec J; LeDoux JE Ann N Y Acad Sci; 2006 Jul; 1071():521-4. PubMed ID: 16891611 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological approach to functional reorganization: the role of norepinephrine. Goldstein LB Rev Neurol (Paris); 1999; 155(9):731-6. PubMed ID: 10528358 [TBL] [Abstract][Full Text] [Related]
16. New drug development for post-traumatic stress disorder. Berlant J Curr Opin Investig Drugs; 2003 Jan; 4(1):37-41. PubMed ID: 12625026 [TBL] [Abstract][Full Text] [Related]
17. Comment: Prazosin treatment of nightmares related to posttraumatic stress disorder. Strawn JR Ann Pharmacother; 2007 Nov; 41(11):1917-8. PubMed ID: 17911207 [No Abstract] [Full Text] [Related]
18. Propranolol use in the prevention and treatment of posttraumatic stress disorder in military veterans: forgetting therapy revisited. Donovan E Perspect Biol Med; 2010; 53(1):61-74. PubMed ID: 20173296 [TBL] [Abstract][Full Text] [Related]
19. Sensitization in relation to posttraumatic stress disorder. Anisman H Biol Psychiatry; 2011 Sep; 70(5):404-5. PubMed ID: 21820530 [No Abstract] [Full Text] [Related]
20. Case report: use of prazosin for treatment of posttraumatic stress disorder. Griffith LJ Am Fam Physician; 2005 Sep; 72(5):758, 761. PubMed ID: 16156334 [No Abstract] [Full Text] [Related] [Next] [New Search]